+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Indonesia Digital Diabetes Management Market Outlook 2020-2030

  • PDF Icon


  • 107 Pages
  • January 2022
  • Region: Indonesia
  • Research Nester Pvt. Ltd
  • ID: 5559855

Indonesia Digital Diabetes Management Market Analysis 2020-2030

The Indonesia digital diabetes management market is anticipated to grow with a CAGR of 17.97% during the forecast period, i.e., 2021-2030. Factors such as the increasing prevalence of diabetes in Indonesia, along with the growing adoption of digital health solutions to tackle the disease are projected to contribute to the growth of the market in the coming years. Besides this, factors such as the increasing advancement in healthcare technologies, rising internet population in Indonesia, and the numerous benefits associated with digital diabetes management solutions are expected to drive the growth of the market in the coming years. The Indonesia digital diabetes management market is estimated to garner a revenue of near to USD 610 Million by the end of 2030, up from a revenue of around USD 120 Million in the year 2020.

The Indonesia digital diabetes management market is segmented by numerous segments, which include segmentation by product & service, device type, diabetes type, and by end-user. Based on end-user, the market is segmented into home care settings, hospitals & specialty diabetes clinics, academic & research institutes, sports & gym centers, and others. The hospitals & specialty diabetes clinics segment, out of all the other segments, is anticipated to garner the largest revenue of about USD 210 Million by the end of 2030. Moreover, in the year 2020, the segment generated the largest revenue of near to USD 40 Million.

Some of the prominent industry leaders in the Indonesia digital diabetes management market that are included in our report are Brighter AB, F.Hoffmann-La Roche Ltd, Medtronic, Azumio Inc., Smart Meter LLC, Abbott, B. Braun Melsungen AG, Biocon, Becton, Dickinson and Company, and others.

Table of Contents

1. Market Definition
1.1. Definition
1.2. Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. Executive Summary - Indonesia Digital Diabetes Management Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities7. Major Roadblocks for the Market Growth8. Regulatory and Standards Landscape9. Industry Risk Analysis10. Pricing Analysis11. Value Chain Analysis12. Industry Growth Outlook13. Epidemiology Analysis14. Impact of COVID-19 on the Digital Diabetes Management Market15. Product Feature Analysis16. Competitive Positioning
17. Competitive Structure
17.1. Market Share Analysis, 2020
17.2. Competitive Benchmarking
17.3. Company Profiles
17.3.1. Brighter AB
17.3.2. F.Hoffmann-La Roche Ltd
17.3.3. Medtronic
17.3.4. Azumio Inc.
17.3.5. Smart Meter LLC
17.3.6. Abbott
17.3.7. B. Braun Melsungen AG
17.3.8. Biocon
17.3.9. Becton, Dickinson and Company
18. Indonesia Digital Diabetes Management Market Outlook 2020-2030
18.1. Market Overview
18.2. By Value (USD Million)
19. Indonesia Digital Diabetes Management Market - Segmentation Analysis 2020-2030
19.1. Product & Service
19.1.1. Device, 2020-2030F (USD Million) Smart Glucose Meters, 2020-2030F (USD Million) Continuous Glucose Monitoring (CGM) Systems, 2020-2030F (USD Million) Smart Insulin Pumps, 2020-2030F (USD Million) Tubeless/Patch Pump, 2020-2030F (USD Million) Closed Loop Pump, 2020-2030F (USD Million) Others, 2020-2030F (USD Million) Smart Insulin Pens, 2020-2030F (USD Million)
19.1.2. Services Application, 2020-2030F (USD Million) Diabetes & Blood Glucose Tracking Apps, 2020-2030F (USD Million) Obesity & Diet Management Apps, 2020-2030F (USD Million) Diabetes Management Software & Platform, 2020-2030F (USD Million)
19.2. Device Type
19.2.1. Handheld Devices, 2020-2030F (USD Million)
19.2.2. Wearable Devices, 2020-2030F (USD Million)
19.3. Diabetes Type
19.3.1. Type 1, 2020-2030F (USD Million)
19.3.2. Type 2, 2020-2030F (USD Million)
19.4. End-User
19.4.1. Home Care Settings, 2020-2030F (USD Million)
19.4.2. Hospitals & Specialty Diabetes Clinics, 2020-2030F (USD Million)
19.4.3. Academic & Research Institutes, 2020-2030F (USD Million)
19.4.4. Sports & Gym Centers, 2020-2030F (USD Million)
19.4.5. Others, 2020-2030F (USD Million)

Companies Mentioned

  • Brighter AB
  • F.Hoffmann-La Roche Ltd
  • Medtronic
  • Azumio Inc.
  • Smart Meter LLC
  • Abbott
  • B. Braun Melsungen AG
  • Biocon
  • Becton
  • Dickinson and Company